Navigating the legal risks of generic drug substitution. Learn how PLIVA v. Mensing affects pharmacist liability, manage NTI drug risks, and implement state-compliant protocols to protect your practice.
Narrow therapeutic index drugs require tighter bioequivalence standards to ensure patient safety. Learn how the FDA, EMA, and Health Canada regulate generics like warfarin, levothyroxine, and digoxin - and why even small differences matter.